Dashboard
Manage Tickers

CGEMCullinan Oncology, Inc.

Nasdaq cullinanoncology.com


$ 19.60 $ 0.74 (3.92 %)    

Friday, 30-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 19.6
$ 19.60 x 100
$ 19.63 x 100
-- - --
$ 7.64 - $ 30.19
397,320
na
1.14B
$ 0.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-14-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mercks-13b-deal-for-potential-autoimmune-disorder-candidate-is-relevant-to-cullinans-investigational-drug-says-analyst
Merck's $1.3B Deal For Potential Autoimmun...
08/09/2024 19:18:10

Merck has agreed to acquire CN201, a bispecific antibody from Curon Biopharmaceutical, for $700 million. This acquisition aims ...

wedbush-reiterates-outperform-on-cullinan-therapeutics-maintains-36-price-target
Wedbush Reiterates Outperform on Cullinan ...
08/09/2024 14:02:15

Wedbush analyst Robert Driscoll reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Outperform and maintains $36 price tar...

cullinan-therapeutics-cash-cash-equivalents-investments-and-interest-receivable-were-6649m-as-of-june-30-2024-cullinan-continues-to-expect-its-cash-resources-to-provide-runway-into-2028-based-on-its-current-operating-plan
Cullinan Therapeutics Cash, Cash Equivalen...
08/08/2024 12:00:36

cullinan-therapeutics-q2-2024-gaap-eps-075-misses-073-estimate
Cullinan Therapeutics Q2 2024 GAAP EPS $(0...
08/08/2024 11:59:55

hc-wainwright--co-reiterates-buy-on-cullinan-therapeutics-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Cull...
06/03/2024 10:09:55

HC Wainwright & Co. analyst Edward White reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and maintains $28 pri...

reported-saturday-cullinan-therapeutics-announced-initial-data-from-pivotal-phase-2b-rezilient1-study-of-zipalertinib
Reported Saturday, Cullinan Therapeutics A...
06/03/2024 08:23:23

As of a January 12, 2024 data cut-off, 31 patients had been enrolled. Patients had received a median of three prior systemic an...

hc-wainwright--co-reiterates-buy-on-cullinan-therapeutics-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Cull...
05/24/2024 10:55:18

HC Wainwright & Co. analyst Edward White reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and maintains $28 pri...

cullinan-therapeutics-files-for-resale-of-up-to-144m-shares-by-the-selling-stockholders
Cullinan Therapeutics Files For Resale Of ...
05/16/2024 20:45:15

- SEC Filing

hc-wainwright--co-maintains-buy-on-cullinan-therapeutics-lowers-price-target-to-28
HC Wainwright & Co. Maintains Buy on Culli...
05/16/2024 15:50:57

HC Wainwright & Co. analyst Edward White maintains Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and lowers the price t...

wedbush-reiterates-outperform-on-cullinan-therapeutics-maintains-36-price-target
Wedbush Reiterates Outperform on Cullinan ...
05/16/2024 12:22:58

Wedbush analyst Robert Driscoll reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Outperform and maintains $36 price tar...

stifel-initiates-coverage-on-cullinan-therapeutics-with-buy-rating-announces-price-target-of-40
Stifel Initiates Coverage On Cullinan Ther...
05/01/2024 09:49:35

Stifel analyst Bradley Canino initiates coverage on Cullinan Therapeutics (NASDAQ:CGEM) with a Buy rating and announces Pric...

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

cullinan-therapeutics-announces-appointment-of-mary-kay-fenton-as-chief-financial-officer
Cullinan Therapeutics Announces Appointmen...
04/29/2024 11:06:09

why-aon-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

skechers-reports-upbeat-earnings-joins-tutor-perini-appfolio-newell-brands-and-other-big-stocks-moving-higher-on-friday
Skechers Reports Upbeat Earnings, Joins Tu...
04/26/2024 14:45:17

why-is-cullinan-therapeutics-stock-trading-higher-on-wednesday
Why Is Cullinan Therapeutics Stock Trading...
04/24/2024 18:29:17

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN...

hilton-worldwide-reports-upbeat-results-joins-hasbro-vertiv-holdings-and-other-big-stocks-moving-higher-on-wednesday
Hilton Worldwide Reports Upbeat Results, J...
04/24/2024 15:19:08

cullinan-therapeutics-to-present-clinical-data-from-phase-1-study-evaluating-novel-anti-micab-antibody-cln-619-as-monotherapy-and-in-combination-with-a-checkpoint-inhibitor-in-patients-with-advanced-solid-tumors-at-asco-2024
Cullinan Therapeutics To Present Clinical ...
04/24/2024 14:10:50

Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION